197 related articles for article (PubMed ID: 24411941)
1. Regulation of steatohepatitis and PPARγ signaling by distinct AP-1 dimers.
Hasenfuss SC; Bakiri L; Thomsen MK; Williams EG; Auwerx J; Wagner EF
Cell Metab; 2014 Jan; 19(1):84-95. PubMed ID: 24411941
[TBL] [Abstract][Full Text] [Related]
2. Liver cancer development driven by the AP-1/c-Jun~Fra-2 dimer through c-Myc.
Bakiri L; Hasenfuss SC; Guío-Carrión A; Thomsen MK; Hasselblatt P; Wagner EF
Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2404188121. PubMed ID: 38657045
[TBL] [Abstract][Full Text] [Related]
3. Perfluorooctanoic acid (PFOA) affects distinct molecular signalling pathways in human primary hepatocytes.
Buhrke T; Krüger E; Pevny S; Rößler M; Bitter K; Lampen A
Toxicology; 2015 Jul; 333():53-62. PubMed ID: 25868421
[TBL] [Abstract][Full Text] [Related]
4. Presence of distinct AP-1 dimers in normal and transformed rat hepatocytes under basal conditions and after epidermal growth factor stimulation.
Nadori F; Lardeux B; Rahmani M; Bringuier A; Durand-Schneider AM; Bernuau D
Hepatology; 1997 Dec; 26(6):1477-83. PubMed ID: 9397987
[TBL] [Abstract][Full Text] [Related]
5. A FATal AP-1 dimer switch in hepatosteatosis.
Bakiri L; Hasenfuss SC; Wagner EF
Cell Cycle; 2014; 13(8):1218-9. PubMed ID: 24621495
[No Abstract] [Full Text] [Related]
6. Deletion of sphingosine kinase 1 ameliorates hepatic steatosis in diet-induced obese mice: Role of PPARγ.
Chen J; Wang W; Qi Y; Kaczorowski D; McCaughan GW; Gamble JR; Don AS; Gao X; Vadas MA; Xia P
Biochim Biophys Acta; 2016 Feb; 1861(2):138-147. PubMed ID: 26615875
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.
Svegliati-Baroni G; Saccomanno S; Rychlicki C; Agostinelli L; De Minicis S; Candelaresi C; Faraci G; Pacetti D; Vivarelli M; Nicolini D; Garelli P; Casini A; Manco M; Mingrone G; Risaliti A; Frega GN; Benedetti A; Gastaldelli A
Liver Int; 2011 Oct; 31(9):1285-97. PubMed ID: 21745271
[TBL] [Abstract][Full Text] [Related]
8. LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a/PPARγ axis in non-alcoholic fatty liver disease.
Liu J; Tang T; Wang GD; Liu B
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31064820
[No Abstract] [Full Text] [Related]
9. Promoter specificity and biological activity of tethered AP-1 dimers.
Bakiri L; Matsuo K; Wisniewska M; Wagner EF; Yaniv M
Mol Cell Biol; 2002 Jul; 22(13):4952-64. PubMed ID: 12052899
[TBL] [Abstract][Full Text] [Related]
10. Restriction to Fos family members of Trip6-dependent coactivation and glucocorticoid receptor-dependent trans-repression of activator protein-1.
Diefenbacher M; Sekula S; Heilbock C; Maier JV; Litfin M; van Dam H; Castellazzi M; Herrlich P; Kassel O
Mol Endocrinol; 2008 Aug; 22(8):1767-80. PubMed ID: 18535250
[TBL] [Abstract][Full Text] [Related]
11. The function of heterodimeric AP-1 comprised of c-Jun and c-Fos in activin mediated Spemann organizer gene expression.
Lee SY; Yoon J; Lee HS; Hwang YS; Cha SW; Jeong CH; Kim JI; Park JB; Lee JY; Kim S; Park MJ; Dong Z; Kim J
PLoS One; 2011; 6(7):e21796. PubMed ID: 21829441
[TBL] [Abstract][Full Text] [Related]
12. Heterodimerization with different Jun proteins controls c-Fos intranuclear dynamics and distribution.
Malnou CE; Brockly F; Favard C; Moquet-Torcy G; Piechaczyk M; Jariel-Encontre I
J Biol Chem; 2010 Feb; 285(9):6552-62. PubMed ID: 20053986
[TBL] [Abstract][Full Text] [Related]
13. NF-kappaB and AP-1 connection: mechanism of NF-kappaB-dependent regulation of AP-1 activity.
Fujioka S; Niu J; Schmidt C; Sclabas GM; Peng B; Uwagawa T; Li Z; Evans DB; Abbruzzese JL; Chiao PJ
Mol Cell Biol; 2004 Sep; 24(17):7806-19. PubMed ID: 15314185
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of c-Jun in nonalcoholic fatty liver disease.
Dorn C; Engelmann JC; Saugspier M; Koch A; Hartmann A; Müller M; Spang R; Bosserhoff A; Hellerbrand C
Lab Invest; 2014 Apr; 94(4):394-408. PubMed ID: 24492282
[TBL] [Abstract][Full Text] [Related]
15. Obesity-induced activation of JunD promotes myocardial lipid accumulation and metabolic cardiomyopathy.
Costantino S; Akhmedov A; Melina G; Mohammed SA; Othman A; Ambrosini S; Wijnen WJ; Sada L; Ciavarella GM; Liberale L; Tanner FC; Matter CM; Hornemann T; Volpe M; Mechta-Grigoriou F; Camici GG; Sinatra R; Lüscher TF; Paneni F
Eur Heart J; 2019 Mar; 40(12):997-1008. PubMed ID: 30629164
[TBL] [Abstract][Full Text] [Related]
16. Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-alpha mediated repression of viral transcription and modification of the AP-1 transcription complex.
Soto U; Das BC; Lengert M; Finzer P; zur Hausen H; Rösl F
Oncogene; 1999 May; 18(21):3187-98. PubMed ID: 10359524
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the role of activator protein-1 on transcription of the mouse steroidogenic acute regulatory protein gene.
Manna PR; Eubank DW; Stocco DM
Mol Endocrinol; 2004 Mar; 18(3):558-73. PubMed ID: 14673133
[TBL] [Abstract][Full Text] [Related]
18. DEP-induced fra-1 expression correlates with a distinct activation of AP-1-dependent gene transcription in the lung.
Zhang Q; Kleeberger SR; Reddy SP
Am J Physiol Lung Cell Mol Physiol; 2004 Feb; 286(2):L427-36. PubMed ID: 14565943
[TBL] [Abstract][Full Text] [Related]
19. Binding site specificity and factor redundancy in activator protein-1-driven human papillomavirus chromatin-dependent transcription.
Wang WM; Wu SY; Lee AY; Chiang CM
J Biol Chem; 2011 Nov; 286(47):40974-86. PubMed ID: 21937452
[TBL] [Abstract][Full Text] [Related]
20. Identification of SWI.SNF complex subunit BAF60a as a determinant of the transactivation potential of Fos/Jun dimers.
Ito T; Yamauchi M; Nishina M; Yamamichi N; Mizutani T; Ui M; Murakami M; Iba H
J Biol Chem; 2001 Jan; 276(4):2852-7. PubMed ID: 11053448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
